#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14718	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2055	712.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1658	1658	T	795	T	707	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14718	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2055	712.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1392	1392	C	847	C,G	763,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27104	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3621	746.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1767	1767	A	918	A	817	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27104	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3621	746.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2401	2401	C	876	C,A	785,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27104	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3621	746.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2475	2475	A	889	A	807	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27104	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3621	746.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3027	3027	C	804	C	727	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1920	folP	855	855	100.0	folP.l6.c4.ctg.1	1414	135.1	1	SNP	p	R229S	1	.	.	685	687	AGC	981	983	AGC	198;199;201	A,C;G;C,T	179,1;180;178,1	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5454	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3390	160.4	1	SNP	p	S91F	1	.	.	271	273	TTC	602	604	TTC	160;159;159	T;T;C,A	144;143;141,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5454	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3390	160.4	1	SNP	p	G95N	0	.	.	283	285	GGC	614	616	GGC	151;147;149	G;G;C	138;132;134	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5454	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3390	160.4	1	SNP	p	D95G	1	.	.	283	285	GGC	614	616	GGC	151;147;149	G;G;C	138;132;134	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1772	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1295	136.5	1	SNP	p	G45D	0	.	.	133	135	GGC	441	443	GGC	250;250;251	G;G;C	223;222;227	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	844	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1070	78.7	0	.	n	.	0	A197.	DEL	197	197	A	629	629	A	203	A	186	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4992	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2962	168.1	0	.	p	.	0	V265I	NONSYN	793	795	GTA	1148	1150	ATA	196;196;194	A;T;A	180;176;176	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4992	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2962	168.1	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1505	1507	GTC	193;194;194	G;T;C	174;175;175	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4992	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2962	168.1	1	SNP	p	D86N	0	.	.	256	258	GAC	611	613	GAC	200;198;196	G;A;C,T	183;177;177,1	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4992	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2962	168.1	1	SNP	p	S87R	1	.	.	259	261	CGT	614	616	CGT	198;197;198	C;G;T	181;177;178	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4992	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2962	168.1	1	SNP	p	R87W	0	.	.	259	261	CGT	614	616	CGT	198;197;198	C;G;T	181;177;178	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4992	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2962	168.1	1	SNP	p	R87I	0	.	.	259	261	CGT	614	616	CGT	198;197;198	C;G;T	181;177;178	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4992	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2962	168.1	1	SNP	p	S88P	0	.	.	262	264	TCC	617	619	TCC	200;199;201	T;C;C	179;176;179	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4488	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2489	179.4	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1310	1312	TGC	219;215;213	T;G;C	194;190;193	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4488	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2489	179.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1520	1522	GGC	223;218;219	G;G;C	204;202;200	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4174	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2271	183.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1217	1219	GCA	254;254;255	G;C;A	231;230;232	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4174	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2271	183.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1220	1222	ATC	256;256;256	A;T;C	234;234;233	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4174	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2271	183.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1232	1234	GTG	264;262;264	G;T;G	237;235;240	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4174	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2271	183.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1232	1234	GTG	264;262;264	G;T;G	237;235;240	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4174	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2271	183.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1736	1738	ACC	203;204;206	A;C;C	173;172;175	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4174	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2271	183.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1790	1792	GCG	207;209;211	G;C;G	179;167;175	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4174	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2271	183.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1790	1792	GCG	207;209;211	G;C;G	179;167;175	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4174	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2271	183.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1913	1915	GGC	178;179;181	G;G;C	158;160;161	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4174	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2271	183.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1922	1924	GGC	178;175;173	G,T;G;C	149,1;151;147	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4174	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2271	183.0	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1940	1942	TCG	184;184;183	T,G;C;G	122,12;140;140	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5890	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	2991	196.1	0	.	p	.	0	E418G	NONSYN	1252	1254	GAG	1535	1537	GGG	216;218;213	G;G;G	183;189;183	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5890	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	2991	196.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1544	1546	CCG	213;210;209	C,G;C,T;G	180,1;182,1;176	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.WHO_U_01087c	porA.WHO_U_01087c	1	0	539	2044	porA	1188	1188	93.94	porA.l15.c4.ctg.1	1826	111.5	0	.	p	.	0	A38L	NONSYN	112	114	GCG	389	391	CTG	98;96;99	C;T;G	94;92;93	.	.
porA.WHO_U_01087c	porA.WHO_U_01087c	1	0	539	2044	porA	1188	1188	93.94	porA.l15.c4.ctg.1	1826	111.5	0	.	p	.	0	P44fs	FSHIFT	130	130	C	407	407	C	102	C	95	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	306	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	309	36.4	0	.	p	.	0	V258L	NONSYN	772	774	GTA	94	96	TTA	50;51;50	T;T;A	45;46;46	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	306	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	309	36.4	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	139	141	CAT	60;58;58	C,G;A;T,G	49,1;47;46,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	306	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	309	36.4	0	.	p	.	0	D274S	NONSYN	820	822	GAT	142	144	AGT	57;56;56	A;G;T,G	46;46;44,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	306	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	309	36.4	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	151	153	TAC	56;56;56	T;A;C	45;47;46	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	306	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	309	36.4	0	.	p	.	0	R307A	NONSYN	919	921	AGA	241	243	GCA	15;15;15	G;C;A	15;15;15	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	306	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	309	36.4	0	.	p	.	0	T311A	NONSYN	931	933	ACA	253	255	GCA	16;16;16	G;C;A	16;15;16	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	306	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	309	36.4	0	.	p	.	0	E312D	NONSYN	934	936	GAA	256	258	GAC	16;15;14	G;A;C	16;15;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	306	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	309	36.4	0	.	p	.	0	F314I	NONSYN	940	942	TTC	262	264	ATC	16;16;16	A;T;C	16;16;16	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	306	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	309	36.4	0	.	p	.	0	A316S	NONSYN	946	948	GCG	268	270	TCG	15;15;15	T;C;G	13;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	306	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	309	36.4	0	.	p	.	0	V318A	NONSYN	952	954	GTC	274	276	GCC	14;14;14	G;C;C	10;13;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	306	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	309	36.4	0	.	p	.	0	G319S	NONSYN	955	957	GGC	277	279	AGC	14;14;13	A;G;C	10;11;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	306	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	309	36.4	0	.	p	.	0	G320A	NONSYN	958	960	GGT	280	282	GCC	13;14;14	G;C;C	12;13;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	306	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	309	36.4	0	.	p	.	0	G322V	NONSYN	964	966	GGT	286	288	GTT	13;13;13	G;T;T	9;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	306	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	309	36.4	0	.	p	.	0	H325Q	NONSYN	973	975	CAC	295	297	CAA	12;11;9	C;A;A,C	8;7;0,5	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2786	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1542	180.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	469	471	GAA	269;271;270	G;A;A	238;240;243	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2786	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1542	180.3	0	.	p	.	0	D121G	NONSYN	361	363	GAC	718	720	GGC	237;237;238	G;G;C	210;206;209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2786	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1542	180.3	0	.	p	.	0	N134D	NONSYN	400	402	AAT	757	759	GAT	251;253;254	G;A;T	232;232;227	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2786	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1542	180.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	880	882	TCA	271;272;271	T,A;C;A	239,1;242;238	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2786	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1542	180.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1009	1011	GTC	224;220;223	G;T;C	203;204;206	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2786	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1542	180.3	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1021	1023	TCT	220;216;217	T,C;C;T	200,1;201;201	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2786	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1542	180.3	0	.	p	.	0	G255_T256del	DEL	763	763	G	1119	1119	T	228	T	211	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2786	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1542	180.3	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1333	1335	GCA	221;220;221	G;C;A	202;200;203	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2786	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1542	180.3	1	SNP	p	G120K	1	.	.	358	360	AAG	715	717	AAG	236;237;238	A;A;G	211;212;210	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10570	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4725	223.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1911	1913	AAT	236;240;239	A;A;T	208;212;207	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1082	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1079	100.0	1	SNP	p	V57M	1	.	.	169	171	ATG	533	535	ATG	234;232;231	A;T;G	212;210;208	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
